This is a summary of results from a published scientific article. You can read the original article published in NEJM Evidence, called “Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate Cancer at: https://evidence.nejm.org/doi/10.1056/EVIDoa2300023
Related Articles
ArteraAI Achieves SOC 2 Type II Security Compliance Certification
ArteraAI x SOC 2 As part of our commitment to cybersecurity, we are proud to announce that ArteraAI is now SOC 2 Type II cert [...]
ArteraAI Predictive Models
ArteraAI is a leading precision medicine company developing AI tests to personalize cancer therapy. Download the pdf.